Entry - #600994 - DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5 - OMIM
# 600994

DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7p15.3 Deafness, autosomal dominant 5 600994 AD 3 GSDME 608798
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Ears
- Hearing loss, sensorineural, progressive (high frequencies first affected, all frequencies later affected)
MISCELLANEOUS
- Variable age of onset, ranging from 11 to 50 years
MOLECULAR BASIS
- Caused by mutation in the DFNA5 gene (608798.0001)
Deafness, autosomal dominant - PS124900 - 76 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.12 Deafness, autosomal dominant 85 AD 3 620227 USP48 617445
1p34.3 Deafness, autosomal dominant 2B AD 3 612644 GJB3 603324
1p34.3 ?Deafness, autosomal dominant 88 AD 3 620283 EPHA10 611123
1p34.2 Deafness, autosomal dominant 2A AD 3 600101 KCNQ4 603537
1p21.1 Deafness, autosomal dominant 37 AD 3 618533 COL11A1 120280
1q21-q23 Deafness, autosomal dominant 49 AD 2 608372 DFNA49 608372
1q21.3 Deafness, autosomal dominant 87 AD 3 620281 PI4KB 602758
1q23.3 Deafness, autosomal dominant 7 AD 3 601412 LMX1A 600298
1q44 Deafness, autosomal dominant 34, with or without inflammation AD 3 617772 NLRP3 606416
2p21-p12 Deafness, autosomal dominant 58 AD 4 615654 DFNA58 615654
2p12 Deafness, autosomal dominant 43 AD 2 608394 DFNA43 608394
2p11.2 ?Deafness, autosomal dominant 81 AD 3 619500 ELMOD3 615427
2q23-q24.3 Deafness, autosomal dominant 16 AD 2 603964 DFNA16 603964
3p25.3 Deafness, autosomal dominant 82 AD 3 619804 ATP2B2 108733
3q21.3 ?Deafness, autosomal dominant 70 AD 3 616968 MCM2 116945
3q22 Deafness, autosomal dominant 18 AD 2 606012 DFNA18 606012
3q23 Deafness, autosomal dominant 76 AD 3 618787 PLS1 602734
3q28 ?Deafness, autosomal dominant 44 AD 3 607453 CCDC50 611051
4p16.1 Deafness, autosomal dominant 6/14/38 AD 3 600965 WFS1 606201
4q12 Deafness, autosomal dominant 27 AD 3 612431 REST 600571
4q21.22 ?Deafness, autosomal dominant 79 AD 3 619086 SCD5 608370
4q22.2 ?Deafness, autosomal dominant 89 AD 3 620284 ATOH1 601461
4q35-qter Deafness, autosomal dominant 24 AD 2 606282 DFNA24 606282
5q13.2 ?Deafness, autosomal dominant 83 AD 3 619808 MAP1B 157129
5q23.3 Deafness, autosomal dominant 78 AD 3 619081 SLC12A2 600840
5q31.1-q32 Deafness, autosomal dominant 52 AD 2 607683 DFNA52 607683
5q31 Deafness, autosomal dominant 54 AD 2 615649 DFNA54 615649
5q31.3 Deafness, autosomal dominant 1, with or without thrombocytopenia AD 3 124900 DIAPH1 602121
5q32 Deafness, autosomal dominant 15 AD 3 602459 POU4F3 602460
6p22.3 Deafness, autosomal dominant 21 AD 3 607017 RIPOR2 611410
6p21.3 Deafness, autosomal dominant 31 AD 2 608645 DFNA31 608645
6p21.33 ?Deafness, autosomal dominant 72 AD 3 617606 SLC44A4 606107
6p21.32 Deafness, autosomal dominant 13 AD 3 601868 COL11A2 120290
6q14.1 Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy AD 3 606346 MYO6 600970
6q14.1 Deafness, autosomal dominant 22 AD 3 606346 MYO6 600970
6q21 ?Deafness, autosomal dominant 66 AD 3 616969 CD164 603356
6q23.2 Deafness, autosomal dominant 10 AD 3 601316 EYA4 603550
7p15.3 Deafness, autosomal dominant 5 AD 3 600994 GSDME 608798
7p14.3 ?Deafness, autosomal dominant 74 AD 3 618140 PDE1C 602987
7q22.1 ?Deafness, autosomal dominant 75 AD 3 618778 TRRAP 603015
7q32.2 Deafness, autosomal dominant 50 AD 3 613074 MIR96 611606
8q22.3 Deafness, autosomal dominant 28 AD 3 608641 GRHL2 608576
9p22-p21 Deafness, autosomal dominant 47 AD 2 608652 DFNA47 608652
9q21.11 Deafness, autosomal dominant 51 AD 4 613558 DFNA51 613558
9q21.13 Deafness, autosomal dominant 36 AD 3 606705 TMC1 606706
9q33.1 Deafness, autosomal dominant 56 AD 3 615629 TNC 187380
10p12.1 Deafness, autosomal dominant 90 AD 3 620722 MYO3A 606808
11p14.2-q12.3 Deafness, autosomal dominant 59 AD 2 612642 DFNA59 612642
11q13.5 Deafness, autosomal dominant 11 AD 3 601317 MYO7A 276903
11q23.3 Deafness, autosomal dominant 8/12 AD 3 601543 TECTA 602574
12q13-q14 Deafness, autosomal dominant 48 AD 2 607841 DFNA48 607841
12q21.31 Deafness, autosomal dominant 73 AD 3 617663 PTPRQ 603317
12q21.32 Deafness, autosomal dominant 69, unilateral or asymmetric AD 3 616697 KITLG 184745
12q23.1 Deafness, autosomal dominant 25 AD 3 605583 SLC17A8 607557
12q24.31 Deafness, autosomal dominant 64 AD 3 614152 DIABLO 605219
12q24.33 Deafness, autosomal dominant 41 AD 3 608224 P2RX2 600844
13q12.11 Deafness, autosomal dominant 3A AD 3 601544 GJB2 121011
13q12.11 Deafness, autosomal dominant 3B AD 3 612643 GJB6 604418
13q34 Deafness, autosomal dominant 33 AD 2 614211 DFNA33 614211
13q34 Deafness, autosomal dominant 84 AD 3 619810 ATP11A 605868
14q11.2-q12 Deafness, autosomal dominant 53 AD 2 609965 DFNA53 609965
14q12 Deafness, autosomal dominant 9 AD 3 601369 COCH 603196
14q23.1 Deafness, autosomal dominant 23 AD 3 605192 SIX1 601205
15q21.2 ?Deafness, autosomal dominant 71 AD 3 617605 DMXL2 612186
15q25-q26 Deafness, autosomal dominant 30 AD 2 606451 DFNA30 606451
15q25.2 ?Deafness, autosomal dominant 68 AD 3 616707 HOMER2 604799
16p13.3 Deafness, autosomal dominant 65 AD 3 616044 TBC1D24 613577
16p13.11 ?Deafness, autosomal dominant 77 AD 3 618915 ABCC1 158343
16p12.2 Deafness, autosomal dominant 40 AD 3 616357 CRYM 123740
17q25.3 Deafness, autosomal dominant 20/26 AD 3 604717 ACTG1 102560
18p11.32 ?Deafness, autosomal dominant 86 AD 3 620280 THOC1 606930
18q11.1-q11.2 Deafness, autosomal dominant 80 AD 3 619274 GREB1L 617782
19q13.31-q13.32 Deafness, autosomal dominant 4B AD 3 614614 CEACAM16 614591
19q13.33 Deafness, autosomal dominant 4A AD 3 600652 MYH14 608568
20q13.33 Deafness, autosomal dominant 67 AD 3 616340 OSBPL2 606731
22q12.3 Deafness, autosomal dominant 17 AD 3 603622 MYH9 160775

TEXT

A number sign (#) is used with this entry because autosomal dominant deafness-5 (DFNA5) is caused by heterozygous mutation in the DFNA5 gene (GSDME; 608798) on chromosome 7p15.


Clinical Features

Huizing et al. (1966, 1966) studied 5 generations of an extensive Dutch kindred in which 67 persons had noncongenital progressive perceptive deafness. Onset was in early childhood with impairment of high frequencies. The loss increased rapidly with gradual extension of the impairment to lower frequencies.

Huizing et al. (1983) and van den Wijngaart et al. (1985, 1985) provided follow-up on the family reported by Huizing et al. (1966, 1966).


Mapping

In the extended Dutch kindred with autosomal dominant progressive hearing loss starting in the high frequencies originally described by Huizing et al. (1966, 1966), Van Camp et al. (1995) used linkage analysis to localize the causative mutation to a 15-cM interval between markers D7S493 and D7S632. These markers had previously been mapped to 7p15 by in situ hybridization (Green et al., 1994).

Van Laer et al. (1997) refined the DFNA5 candidate region to less than 2 cM and cloned the region in a YAC contig. The refinement of the candidate region of DFNA5 excluded the HOXA1 gene (142955) as a candidate for mutation in this disorder.


Molecular Genetics

By a positional cloning strategy, Van Laer et al. (1998) isolated a gene from the DFNA5 region that is expressed in the cochlea. In members of the family originally described by Huizing et al. (1966, 1966), they identified an insertion/deletion mutation in intron 7 of this gene that did not affect intron-exon boundaries, but deleted 5 G-triplets at the 3-prime end of the intron (600994.0001). The mutation cosegregated with deafness in the family and caused skipping of exon 8, resulting in premature termination of the open reading frame.

In a Chinese family with autosomal dominant nonsyndromic sensorineural deafness, Yu et al. (2003) identified a 3-bp deletion in the DFNA5 gene (608798.0002) that segregated with the phenotype and was predicted to cause skipping of exon 8, like the DFNA5 mutation previously reported by Van Laer et al. (1998).

In a 5-generation Dutch family with autosomal dominant deafness, Bischoff et al. (2004) identified a splice site mutation in the DFNA5 gene (608798.0003) that caused skipping of exon 8. Because of the relatively low amount of short transcript in affected members in this family, the authors suggested that the mutation may have a dominant-negative effect rather than haploinsufficiency.

Cheng et al. (2007) identified a heterozygous splice site mutation in the DFNA5 gene (608798.0004) in affected members of a large Chinese family with late-onset sensorineural hearing loss. Onset ranged from 11 to 50 years of age, and hearing loss first affected high frequencies but later involved all frequencies. The authors noted that all of the pathogenic mutations described in the DFNA5 gene result in skipping of exon 8, suggesting a very specific gain-of-function effect.

In a 5-generation Iranian family segregating nonsyndromic autosomal dominant sensorineural hearing loss that appeared to map to the DFNA5 locus, Van Laer et al. (2007) identified a heterozygous truncating mutation in exon 5 of the DFNA5 gene. However, further analysis revealed that the mutation did not segregate with hearing loss in this family. The authors stated that linkage to a locus on chromosome 4 was subsequently found (unpublished results). Van Laer et al. (2007) stated that these findings supported the hypothesis that only a very specific gain-of-function mutation caused by skipping of exon 8 can lead to DFNA5-associated hearing loss.

Using 2 next-generation sequencing platforms, Booth et al. (2018) identified 5 families with autosomal dominant postlingual progressive nonsyndromic hearing loss with 3 novel and 2 recurrent mutations in the DFNA5 gene. The 3 novel mutations were missense mutations within exon 8 that were predicted to reduce the efficiency of, or abolish, splicing (see, e.g., Q368E, 608798.0005). Functional impact of these 3 mutations was confirmed in vitro using minigenes. The authors noted that previously overlooked silent mutations within exon 8 could alter splicing, and they suggested that families with high frequency progressive hearing loss linked to the DFNA5 gene should be evaluated for variants in the flanking introns and in the exon itself.


History

Dolowitz and Stephens (1961) described high tone neural deafness present at all ages but more severe in older members of 4 generations of a Mormon kindred. Slow progression of the hearing loss over several decades was well demonstrated.

Paparella et al. (1969) described the anatomic findings in 2 cases of dominant progressive sensorineural deafness. Nance and McConnell (1973) observed a 4-generation kindred.

Higashi (1988) suggested that high-frequency sensorineural hearing loss with autosomal dominant inheritance can be divided into 4 types on the basis of the slope of audiograms. The first type has the steepest audiogram and the fourth has an audiogram close to horizontal; the other 2 types are intermediate.


REFERENCES

  1. Bischoff, A. M. L. C., Luijendijk, M. W. J., Huygen, P. L. M., van Duijnhoven, G., De Leenheer, E. M. R., Oudesluijs, G. G., Van Laer, L., Cremers, F. P. M., Cremers, C. W. R. J., Kremer, H. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol. Neurootol. 9: 34-46, 2004. [PubMed: 14676472, related citations] [Full Text]

  2. Booth, K. T., Azaiez, H., Kahrizi, K., Wang, D., Zhang, Y., Frees, K., Nishimura, C., Najmabadi, H., Smith, R. J. Exonic mutations and exon skipping: lessons learned from DFNA5. Hum. Mutat. 39: 433-440, 2018. [PubMed: 29266521, related citations] [Full Text]

  3. Cheng, J., Han, D. Y., Dai, P., Sun, H. J., Tao, R., Sun, Q., Yan, D., Qin, W., Wang, H. Y., Ouyang, X. M., Yang, S. Z., Cao, J. Y., Feng, G. Y., Du, L. L., Zhang, Y. Z., Zhai, S. Q., Yang, W. Y., Liu, X. Z., He, L., Yuan, H. J. A novel DFNA5 mutation, IVS8+4A-G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family. Clin. Genet. 72: 471-477, 2007. [PubMed: 17868390, related citations] [Full Text]

  4. Dolowitz, D. A., Stephens, F. E. Hereditary nerve deafness. Trans. Am. Otol. Soc. 49: 290-300, 1961. [PubMed: 13887072, related citations]

  5. Green, E. D., Idol, J. R., Mohr-Tidwell, R. M., Braden, V. V., Peluso, D. C., Fulton, R. S., Massa, H. F., Magness, C. L., Wilson, A. M., Kimura, J., Weissenbach, J., Trask, B. J. Integration of physical, genetic and cytogenetic maps of human chromosome 7: isolation and analysis of yeast artificial chromosome clones for 117 mapped genetic markers. Hum. Molec. Genet. 3: 489-501, 1994. [PubMed: 8012362, related citations] [Full Text]

  6. Higashi, K. Heterogeneity of dominant high-frequency sensorineural deafness. Clin. Genet. 33: 424-428, 1988. [PubMed: 3168315, related citations] [Full Text]

  7. Huizing, E. H., Van Bolhuis, A. H., Odenthal, D. W. Studies on progressive hereditary perceptive deafness in a family of 335 members. I. Genetical and general audiological results. Acta Otolaryng. 61: 35-41, 1966. [PubMed: 5919636, related citations] [Full Text]

  8. Huizing, E. H., Van Bolhuis, A. H., Odenthal, D. W. Studies on progressive hereditary perceptive deafness in a family of 335 members. II. Characteristic patterns of hearing deterioration. Acta Otolaryng. 61: 161-167, 1966. [PubMed: 5919633, related citations] [Full Text]

  9. Huizing, E. H., van den Wijngaart, W. S. I. M., Verschuure, J. A follow-up study in a family with dominant progressive inner ear deafness. Acta Otolaryng. 95: 620-626, 1983. [PubMed: 6880675, related citations] [Full Text]

  10. Nance, W. E., McConnell, F. E. Status and progress of research in hereditary deafness. Adv. Hum. Genet. 4: 173-250, 1973. [PubMed: 4205901, related citations] [Full Text]

  11. Paparella, M. M., Sugiura, S., Hoshino, T. Familial progressive sensorineural deafness. Arch. Otolaryng. 90: 44-51, 1969. [PubMed: 5785987, related citations] [Full Text]

  12. Van Camp, G., Coucke, P., Balemans, W., Van Velzen, D., Van de Bilt, C., Van Laer, L., Smith, R. J. H., Fukushima, K., Padberg, G. W., Frants, R. R., Van de Heyning, P., Smith, S. D., Huizing, E. H., Willems, P. J. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum. Molec. Genet. 4: 2159-2163, 1995. [PubMed: 8589696, related citations] [Full Text]

  13. van den Wijngaart, W. S. I. M., Huizing, E. H., Niermeijer, M. F., Verschuure, J., Brocaar, M. P., Blom, W. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. II. Clinical aspects. Audiology 24: 336-342, 1985. [PubMed: 4051882, related citations] [Full Text]

  14. van den Wijngaart, W. S. I. M., Verschuure, J., Brocaar, M. P., Huizing, E. H. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. I. Analysis of hearing deterioration. Audiology 24: 233-240, 1985. [PubMed: 4051873, related citations] [Full Text]

  15. Van Laer, L., Huizing, E. H., Verstreken, M., van Zuijlen, D., Wauters, J. G., Bossuyt, P. J., Van de Heyning, P., McGuirt, W. T., Smith, R. J. H., Willems, P. J., Legan, P. K., Richardson, G. P., Van Camp, G. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nature Genet. 20: 194-197, 1998. [PubMed: 9771715, related citations] [Full Text]

  16. Van Laer, L., Meyer, N. C., Malekpour, M., Riazalhosseini, Y., Moghannibashi, M., Kahrizi, K., Vandevelde, A., Alasti, F., Najmabadi, H., Van Camp, G., Smith, R. J. H. A novel DFNA5 mutation does not cause hearing loss in an Iranian family. J. Hum. Genet. 52: 549-552, 2007. [PubMed: 17427029, related citations] [Full Text]

  17. Van Laer, L., Van Camp, G., van Zuijlen, D., Green, E. D., Verstreken, M., Schatteman, I., Van de Heyning, P., Balemans, W., Coucke, P., Greinwald, J. H., Smith, R. J. H., Huizing, E., Willems, P. Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Europ. J. Hum. Genet. 5: 397-405, 1997. [PubMed: 9450185, related citations]

  18. Yu, C., Meng, X., Zhang, S., Zhao, G., Hu, L., Kong, X. A 3-nucleotide deletion in the polypyrimidine tract of the intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 82: 575-579, 2003. [PubMed: 14559215, related citations] [Full Text]


Sonja A. Rasmussen - updated : 10/01/2021
Marla J. F. O'Neill - updated : 6/1/2009
Cassandra L. Kniffin - updated : 8/21/2008
Marla J. F. O'Neill - updated : 7/9/2004
Victor A. McKusick - updated : 11/24/2003
Michael B. Petersen - updated : 6/23/2003
Victor A. McKusick - updated : 9/25/1998
Victor A. McKusick - updated : 2/17/1998
Creation Date:
Victor A. McKusick : 1/18/1996
alopez : 03/13/2023
carol : 10/04/2021
carol : 10/01/2021
carol : 08/06/2019
carol : 08/02/2019
mgross : 08/22/2017
carol : 02/19/2014
carol : 2/10/2014
carol : 2/10/2014
carol : 1/10/2011
carol : 1/7/2011
wwang : 6/2/2009
terry : 6/1/2009
terry : 12/2/2008
wwang : 9/2/2008
ckniffin : 8/21/2008
carol : 10/23/2006
carol : 7/13/2004
carol : 7/9/2004
carol : 7/9/2004
terry : 7/9/2004
joanna : 6/29/2004
joanna : 3/18/2004
cwells : 11/25/2003
terry : 11/24/2003
cwells : 6/23/2003
carol : 6/12/2001
dkim : 10/12/1998
dkim : 10/1/1998
alopez : 9/29/1998
carol : 9/25/1998
mark : 3/2/1998
terry : 2/17/1998
mark : 7/3/1997
jenny : 6/3/1997
mark : 1/19/1996
mark : 1/19/1996

# 600994

DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5


ORPHA: 90635;   DO: 0110575;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
7p15.3 Deafness, autosomal dominant 5 600994 Autosomal dominant 3 GSDME 608798

TEXT

A number sign (#) is used with this entry because autosomal dominant deafness-5 (DFNA5) is caused by heterozygous mutation in the DFNA5 gene (GSDME; 608798) on chromosome 7p15.


Clinical Features

Huizing et al. (1966, 1966) studied 5 generations of an extensive Dutch kindred in which 67 persons had noncongenital progressive perceptive deafness. Onset was in early childhood with impairment of high frequencies. The loss increased rapidly with gradual extension of the impairment to lower frequencies.

Huizing et al. (1983) and van den Wijngaart et al. (1985, 1985) provided follow-up on the family reported by Huizing et al. (1966, 1966).


Mapping

In the extended Dutch kindred with autosomal dominant progressive hearing loss starting in the high frequencies originally described by Huizing et al. (1966, 1966), Van Camp et al. (1995) used linkage analysis to localize the causative mutation to a 15-cM interval between markers D7S493 and D7S632. These markers had previously been mapped to 7p15 by in situ hybridization (Green et al., 1994).

Van Laer et al. (1997) refined the DFNA5 candidate region to less than 2 cM and cloned the region in a YAC contig. The refinement of the candidate region of DFNA5 excluded the HOXA1 gene (142955) as a candidate for mutation in this disorder.


Molecular Genetics

By a positional cloning strategy, Van Laer et al. (1998) isolated a gene from the DFNA5 region that is expressed in the cochlea. In members of the family originally described by Huizing et al. (1966, 1966), they identified an insertion/deletion mutation in intron 7 of this gene that did not affect intron-exon boundaries, but deleted 5 G-triplets at the 3-prime end of the intron (600994.0001). The mutation cosegregated with deafness in the family and caused skipping of exon 8, resulting in premature termination of the open reading frame.

In a Chinese family with autosomal dominant nonsyndromic sensorineural deafness, Yu et al. (2003) identified a 3-bp deletion in the DFNA5 gene (608798.0002) that segregated with the phenotype and was predicted to cause skipping of exon 8, like the DFNA5 mutation previously reported by Van Laer et al. (1998).

In a 5-generation Dutch family with autosomal dominant deafness, Bischoff et al. (2004) identified a splice site mutation in the DFNA5 gene (608798.0003) that caused skipping of exon 8. Because of the relatively low amount of short transcript in affected members in this family, the authors suggested that the mutation may have a dominant-negative effect rather than haploinsufficiency.

Cheng et al. (2007) identified a heterozygous splice site mutation in the DFNA5 gene (608798.0004) in affected members of a large Chinese family with late-onset sensorineural hearing loss. Onset ranged from 11 to 50 years of age, and hearing loss first affected high frequencies but later involved all frequencies. The authors noted that all of the pathogenic mutations described in the DFNA5 gene result in skipping of exon 8, suggesting a very specific gain-of-function effect.

In a 5-generation Iranian family segregating nonsyndromic autosomal dominant sensorineural hearing loss that appeared to map to the DFNA5 locus, Van Laer et al. (2007) identified a heterozygous truncating mutation in exon 5 of the DFNA5 gene. However, further analysis revealed that the mutation did not segregate with hearing loss in this family. The authors stated that linkage to a locus on chromosome 4 was subsequently found (unpublished results). Van Laer et al. (2007) stated that these findings supported the hypothesis that only a very specific gain-of-function mutation caused by skipping of exon 8 can lead to DFNA5-associated hearing loss.

Using 2 next-generation sequencing platforms, Booth et al. (2018) identified 5 families with autosomal dominant postlingual progressive nonsyndromic hearing loss with 3 novel and 2 recurrent mutations in the DFNA5 gene. The 3 novel mutations were missense mutations within exon 8 that were predicted to reduce the efficiency of, or abolish, splicing (see, e.g., Q368E, 608798.0005). Functional impact of these 3 mutations was confirmed in vitro using minigenes. The authors noted that previously overlooked silent mutations within exon 8 could alter splicing, and they suggested that families with high frequency progressive hearing loss linked to the DFNA5 gene should be evaluated for variants in the flanking introns and in the exon itself.


History

Dolowitz and Stephens (1961) described high tone neural deafness present at all ages but more severe in older members of 4 generations of a Mormon kindred. Slow progression of the hearing loss over several decades was well demonstrated.

Paparella et al. (1969) described the anatomic findings in 2 cases of dominant progressive sensorineural deafness. Nance and McConnell (1973) observed a 4-generation kindred.

Higashi (1988) suggested that high-frequency sensorineural hearing loss with autosomal dominant inheritance can be divided into 4 types on the basis of the slope of audiograms. The first type has the steepest audiogram and the fourth has an audiogram close to horizontal; the other 2 types are intermediate.


REFERENCES

  1. Bischoff, A. M. L. C., Luijendijk, M. W. J., Huygen, P. L. M., van Duijnhoven, G., De Leenheer, E. M. R., Oudesluijs, G. G., Van Laer, L., Cremers, F. P. M., Cremers, C. W. R. J., Kremer, H. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol. Neurootol. 9: 34-46, 2004. [PubMed: 14676472] [Full Text: https://doi.org/10.1159/000074185]

  2. Booth, K. T., Azaiez, H., Kahrizi, K., Wang, D., Zhang, Y., Frees, K., Nishimura, C., Najmabadi, H., Smith, R. J. Exonic mutations and exon skipping: lessons learned from DFNA5. Hum. Mutat. 39: 433-440, 2018. [PubMed: 29266521] [Full Text: https://doi.org/10.1002/humu.23384]

  3. Cheng, J., Han, D. Y., Dai, P., Sun, H. J., Tao, R., Sun, Q., Yan, D., Qin, W., Wang, H. Y., Ouyang, X. M., Yang, S. Z., Cao, J. Y., Feng, G. Y., Du, L. L., Zhang, Y. Z., Zhai, S. Q., Yang, W. Y., Liu, X. Z., He, L., Yuan, H. J. A novel DFNA5 mutation, IVS8+4A-G, in the splice donor site of intron 8 causes late-onset non-syndromic hearing loss in a Chinese family. Clin. Genet. 72: 471-477, 2007. [PubMed: 17868390] [Full Text: https://doi.org/10.1111/j.1399-0004.2007.00889.x]

  4. Dolowitz, D. A., Stephens, F. E. Hereditary nerve deafness. Trans. Am. Otol. Soc. 49: 290-300, 1961. [PubMed: 13887072]

  5. Green, E. D., Idol, J. R., Mohr-Tidwell, R. M., Braden, V. V., Peluso, D. C., Fulton, R. S., Massa, H. F., Magness, C. L., Wilson, A. M., Kimura, J., Weissenbach, J., Trask, B. J. Integration of physical, genetic and cytogenetic maps of human chromosome 7: isolation and analysis of yeast artificial chromosome clones for 117 mapped genetic markers. Hum. Molec. Genet. 3: 489-501, 1994. [PubMed: 8012362] [Full Text: https://doi.org/10.1093/hmg/3.3.489]

  6. Higashi, K. Heterogeneity of dominant high-frequency sensorineural deafness. Clin. Genet. 33: 424-428, 1988. [PubMed: 3168315] [Full Text: https://doi.org/10.1111/j.1399-0004.1988.tb03475.x]

  7. Huizing, E. H., Van Bolhuis, A. H., Odenthal, D. W. Studies on progressive hereditary perceptive deafness in a family of 335 members. I. Genetical and general audiological results. Acta Otolaryng. 61: 35-41, 1966. [PubMed: 5919636] [Full Text: https://doi.org/10.3109/00016486609127040]

  8. Huizing, E. H., Van Bolhuis, A. H., Odenthal, D. W. Studies on progressive hereditary perceptive deafness in a family of 335 members. II. Characteristic patterns of hearing deterioration. Acta Otolaryng. 61: 161-167, 1966. [PubMed: 5919633] [Full Text: https://doi.org/10.3109/00016486609127053]

  9. Huizing, E. H., van den Wijngaart, W. S. I. M., Verschuure, J. A follow-up study in a family with dominant progressive inner ear deafness. Acta Otolaryng. 95: 620-626, 1983. [PubMed: 6880675] [Full Text: https://doi.org/10.3109/00016488309139453]

  10. Nance, W. E., McConnell, F. E. Status and progress of research in hereditary deafness. Adv. Hum. Genet. 4: 173-250, 1973. [PubMed: 4205901] [Full Text: https://doi.org/10.1007/978-1-4615-8261-8_3]

  11. Paparella, M. M., Sugiura, S., Hoshino, T. Familial progressive sensorineural deafness. Arch. Otolaryng. 90: 44-51, 1969. [PubMed: 5785987] [Full Text: https://doi.org/10.1001/archotol.1969.00770030046010]

  12. Van Camp, G., Coucke, P., Balemans, W., Van Velzen, D., Van de Bilt, C., Van Laer, L., Smith, R. J. H., Fukushima, K., Padberg, G. W., Frants, R. R., Van de Heyning, P., Smith, S. D., Huizing, E. H., Willems, P. J. Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum. Molec. Genet. 4: 2159-2163, 1995. [PubMed: 8589696] [Full Text: https://doi.org/10.1093/hmg/4.11.2159]

  13. van den Wijngaart, W. S. I. M., Huizing, E. H., Niermeijer, M. F., Verschuure, J., Brocaar, M. P., Blom, W. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. II. Clinical aspects. Audiology 24: 336-342, 1985. [PubMed: 4051882] [Full Text: https://doi.org/10.3109/00206098509078352]

  14. van den Wijngaart, W. S. I. M., Verschuure, J., Brocaar, M. P., Huizing, E. H. Follow-up study in a family with dominant progressive hereditary sensorineural hearing impairment. I. Analysis of hearing deterioration. Audiology 24: 233-240, 1985. [PubMed: 4051873] [Full Text: https://doi.org/10.3109/00206098509070107]

  15. Van Laer, L., Huizing, E. H., Verstreken, M., van Zuijlen, D., Wauters, J. G., Bossuyt, P. J., Van de Heyning, P., McGuirt, W. T., Smith, R. J. H., Willems, P. J., Legan, P. K., Richardson, G. P., Van Camp, G. Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nature Genet. 20: 194-197, 1998. [PubMed: 9771715] [Full Text: https://doi.org/10.1038/2503]

  16. Van Laer, L., Meyer, N. C., Malekpour, M., Riazalhosseini, Y., Moghannibashi, M., Kahrizi, K., Vandevelde, A., Alasti, F., Najmabadi, H., Van Camp, G., Smith, R. J. H. A novel DFNA5 mutation does not cause hearing loss in an Iranian family. J. Hum. Genet. 52: 549-552, 2007. [PubMed: 17427029] [Full Text: https://doi.org/10.1007/s10038-007-0137-2]

  17. Van Laer, L., Van Camp, G., van Zuijlen, D., Green, E. D., Verstreken, M., Schatteman, I., Van de Heyning, P., Balemans, W., Coucke, P., Greinwald, J. H., Smith, R. J. H., Huizing, E., Willems, P. Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Europ. J. Hum. Genet. 5: 397-405, 1997. [PubMed: 9450185]

  18. Yu, C., Meng, X., Zhang, S., Zhao, G., Hu, L., Kong, X. A 3-nucleotide deletion in the polypyrimidine tract of the intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 82: 575-579, 2003. [PubMed: 14559215] [Full Text: https://doi.org/10.1016/s0888-7543(03)00175-7]


Contributors:
Sonja A. Rasmussen - updated : 10/01/2021
Marla J. F. O'Neill - updated : 6/1/2009
Cassandra L. Kniffin - updated : 8/21/2008
Marla J. F. O'Neill - updated : 7/9/2004
Victor A. McKusick - updated : 11/24/2003
Michael B. Petersen - updated : 6/23/2003
Victor A. McKusick - updated : 9/25/1998
Victor A. McKusick - updated : 2/17/1998

Creation Date:
Victor A. McKusick : 1/18/1996

Edit History:
alopez : 03/13/2023
carol : 10/04/2021
carol : 10/01/2021
carol : 08/06/2019
carol : 08/02/2019
mgross : 08/22/2017
carol : 02/19/2014
carol : 2/10/2014
carol : 2/10/2014
carol : 1/10/2011
carol : 1/7/2011
wwang : 6/2/2009
terry : 6/1/2009
terry : 12/2/2008
wwang : 9/2/2008
ckniffin : 8/21/2008
carol : 10/23/2006
carol : 7/13/2004
carol : 7/9/2004
carol : 7/9/2004
terry : 7/9/2004
joanna : 6/29/2004
joanna : 3/18/2004
cwells : 11/25/2003
terry : 11/24/2003
cwells : 6/23/2003
carol : 6/12/2001
dkim : 10/12/1998
dkim : 10/1/1998
alopez : 9/29/1998
carol : 9/25/1998
mark : 3/2/1998
terry : 2/17/1998
mark : 7/3/1997
jenny : 6/3/1997
mark : 1/19/1996
mark : 1/19/1996